Galaxy Surfactants Q2FY27 PAT Jumps 80% to ₹119.8 Cr on Robust Revenue Growth
Galaxy Surfactants reported Q2 FY27 consolidated revenue of ₹1,816.8 crore, up 36.4% YoY. EBITDA grew 68.4% to ₹195.9 crore, and PAT increased 80.1% to ₹119.8 crore. Volumes saw high-single-digit growth YoY, driven by India and AMET regions. First six months PAT surpassed FY26 full year PAT.
Significant increases in key financial metrics like revenue, EBITDA, and PAT, coupled with exceeding previous full-year performance in just six months, are highly material for investors and indicate strong business momentum.
The company reported strong year-on-year growth in revenue, EBITDA, and PAT, driven by volume growth and an improved product mix. Management commentary also indicates confidence in future growth.
Galaxy Surfactants Limited has announced its unaudited financial results for the quarter and half year ended September 30, 2026.
Consolidated volumes showed high-single-digit growth year-on-year, primarily driven by strong mid-teens growth in India and the AMET regions, indicating resilient customer demand and effective execution. EBITDA saw a significant increase of 68% year-on-year, reaching ₹196 crore, with EBITDA per metric ton rising by 56% to ₹26,920. This growth was attributed to volume-led performance, an enriched Specialty Care portfolio mix, and sustained demand for premium and masstige offerings in both domestic and international markets.
While volumes in Rest of the World markets were impacted by logistics disruptions and elevated freight costs, the demand for premium and masstige Specialty Care products remained healthy. The company reported a total revenue of ₹1,816.8 crore, a 36.4% increase year-on-year, and Profit After Tax (PAT) surged by 80.1% to ₹119.8 crore.
Mr. K. Natarajan, Managing Director, expressed satisfaction with the Q2 FY27 performance, highlighting the broad-based growth in India, recovery in AMET, and sustained momentum in Specialty Care. He emphasized the company's ability to make disciplined commercial decisions and leverage its diversified portfolio, enabling robust performance despite a challenging external environment. Notably, PAT for the first six months of FY27 has already surpassed the PAT for the entire previous financial year. Demand indicators remain encouraging across key markets, though the company remains vigilant regarding developments in West Asia and their potential implications for global logistics, freight rates, and feedstock availability.
What to do with a filing like this
Galaxy Surfactants Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Galaxy Surfactants Limited. Read the original for the full detail.